Pacific Biosciences of California, Inc. (PACB)
NASDAQ · Healthcare
Pacific Biosciences of California, Inc. Income Statement 2009–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenue | 160.0M | 154.0M | 200.5M | 128.3M | 130.5M | 78.9M | 90.9M | 78.6M | 93.5M | 90.7M | 92.8M | 60.6M | 28.2M | 26.0M | 33.9M | 1.7M | 135,000 |
| Gross Profit | 45.8M | 37.3M | 52.8M | 49.0M | 58.9M | 32.6M | 34.6M | 25.1M | 34.7M | 44.2M | 53.5M | 23.4M | 6.4M | 940,000 | 13.0M | 1.7M | 135,000 |
| Profitability | |||||||||||||||||
| Operating Income | -553.9M | -474.3M | -334.5M | -307.2M | -210.4M | -104.4M | -100.5M | -101.0M | -89.8M | -71.2M | -29.1M | -62.9M | -77.5M | -94.3M | -109.8M | — | — |
| EBITDA | — | — | — | — | — | — | — | -93.8M | -81.3M | -67.4M | -25.5M | -58.6M | -71.9M | -87.7M | -104.0M | — | — |
| Net Income | -546.4M | -309.9M | -306.7M | -314.2M | -181.2M | 29.4M | -84.1M | -102.6M | -92.2M | -74.4M | -31.7M | -66.2M | -79.3M | -94.5M | -109.4M | -140.2M | -87.7M |
| Per Share Data | |||||||||||||||||
| EPS (diluted) | $-1.82 | $-1.59 | $-1.21 | $-1.40 | $-0.89 | $0.17 | $-0.55 | $-0.76 | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 300M | 288M | 254M | 225M | 204M | 175M | 153M | 135M | 116M | 93M | 80M | 74M | 66M | 56M | 0M | 53M | — |
Pacific Biosciences of California, Inc. Income Statement — FAQ
Pacific Biosciences of California, Inc. (PACB) income statement over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PACB's income statement history?
The chart and table above show Pacific Biosciences of California, Inc.'s income statement by year and by quarter, including the growth rate.